Compugen (CGEN) EBITDA Margin Growth (3y) (2012 - 2025)
Compugen (CGEN) EBITDA Margin Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 828,504.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7,261.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -2,649.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 9,003.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 30,461.00 |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,029.00 |
| Sep 30, 2024 | 13,179.00 |
| Dec 31, 2023 | 50,830.00 |
| Sep 30, 2021 | -6,283.00 |
| Sep 30, 2018 | 297,650.00 |
| Dec 31, 2016 | -1.63 Mn |
| Sep 30, 2016 | -1.11 Mn |
| Jun 30, 2016 | 2.00 Mn |
| Mar 31, 2016 | -709,180.00 |
| Dec 31, 2015 | 285,767.00 |
| Sep 30, 2015 | 33,634.00 |
| Dec 31, 2013 | 98,754.00 |
| Jun 30, 2013 | -2.13 Mn |
| Mar 31, 2013 | -27,251.00 |
| Dec 31, 2012 | 493,758.00 |
| Sep 30, 2012 | -546,389.00 |